PXXLF
Price
$0.25
Change
-$0.45 (-64.29%)
Updated
Nov 25 closing price
Capitalization
35.81M
RAPT
Price
$8.43
Change
-$1.30 (-13.36%)
Updated
Jun 27 closing price
Capitalization
139.4M
38 days until earnings call
Interact to see
Advertisement

PXXLF vs RAPT

Header iconPXXLF vs RAPT Comparison
Open Charts PXXLF vs RAPTBanner chart's image
Poxel SA
Price$0.25
Change-$0.45 (-64.29%)
Volume$750
Capitalization35.81M
RAPT Therapeutics
Price$8.43
Change-$1.30 (-13.36%)
Volume$593.04K
Capitalization139.4M
PXXLF vs RAPT Comparison Chart in %
Loading...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PXXLF vs. RAPT commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PXXLF is a Hold and RAPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (PXXLF: $0.25 vs. RAPT: $8.43)
Brand notoriety: PXXLF and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PXXLF: 100% vs. RAPT: 490%
Market capitalization -- PXXLF: $35.81M vs. RAPT: $139.4M
PXXLF [@Biotechnology] is valued at $35.81M. RAPT’s [@Biotechnology] market capitalization is $139.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PXXLF’s FA Score shows that 1 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • PXXLF’s FA Score: 1 green, 4 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, PXXLF is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RAPT’s TA Score shows that 4 TA indicator(s) are bullish.

  • RAPT’s TA Score: 4 bullish, 5 bearish.

Price Growth

PXXLF (@Biotechnology) experienced а 0.00% price change this week, while RAPT (@Biotechnology) price change was +13.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

RAPT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPT($139M) has a higher market cap than PXXLF($35.8M). PXXLF YTD gains are higher at: 0.000 vs. RAPT (-33.307).
PXXLFRAPTPXXLF / RAPT
Capitalization35.8M139M26%
EBITDAN/AN/A-
Gain YTD0.000-33.307-
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A3.84M-
FUNDAMENTALS RATINGS
PXXLF: Fundamental Ratings
PXXLF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PXXLFRAPT
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
6%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
7%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCLIF0.180.03
+18.33%
Full Circle Lithium Corp.
TATYY29.370.17
+0.58%
Tate & Lyle, PLC
HBGRF1.85N/A
N/A
Heidelberger Druckmaschinen AG
GAMN0.06N/A
N/A
Great American Food Chain, Inc. (The)
LGGNF3.50-0.15
-4.04%
Legal & General Group Plc

PXXLF and

Correlation & Price change

A.I.dvisor tells us that PXXLF and SEOVF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PXXLF and SEOVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXXLF
1D Price
Change %
PXXLF100%
N/A
SEOVF - PXXLF
29%
Poorly correlated
N/A
RAPT - PXXLF
28%
Poorly correlated
-13.36%
CDTX - PXXLF
24%
Poorly correlated
+2.96%
CLVLF - PXXLF
22%
Poorly correlated
N/A
ABVC - PXXLF
21%
Poorly correlated
+18.26%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been loosely correlated with TRAW. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPT jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-13.36%
TRAW - RAPT
45%
Loosely correlated
N/A
SLGL - RAPT
40%
Loosely correlated
-0.81%
AVXL - RAPT
37%
Loosely correlated
-0.94%
CCCC - RAPT
35%
Loosely correlated
-7.89%
CTMX - RAPT
35%
Loosely correlated
-2.60%
More